VivoSeq
Other

Sex Differences

0

Pipeline Programs

7

Active Trials

0

Companies Involved

Sex Differences is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

13

clinical trials

Completed6 · 46%
Recruiting6 · 46%
Not yet recruiting1 · 8%

Trial Activity

13 trials

Sex Differences in the Vascular Effects of E-cigarette Use
Recruiting··Phase 1·NCT06159608·80 enrolled
Neural and Hormonal Influences on Sex Differences in Risk for AUD
Recruiting··N/A·NCT04929288·100 enrolled
Sex Differences in the Dilatory Response of Compound 21
Completed··Phase 1·NCT05576155·26 enrolled
Sex Differences in Neural Response to Cannabidiol
Completed·YYale University·Phase 1·NCT04777643·19 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)